Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.
| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc. | ADL-018 - (biosimilar to XOLAIR) | Chronic Idiopathic Urticaria (CIU) or Chronic Spontaneous Urticaria (CSU) | BLA Filing | Data Released | subcutaneous | Immunology |
| Amneal Pharmaceuticals Inc. | K-127 | Myasthenia Gravis | NDA Filing | Oral | Neurology | |
| Amneal Pharmaceuticals Inc. | CREXONT (carbidopa and levodopa) - (ELEVATE-PD) | Parkinson's Disease | Phase 3 | Data Released | Oral | Neurology |
| Ampio Pharmaceuticals Inc. | Ampion (AP-013) | Osteoarthritis of the Knee (OAK) | Phase 3 | Intra-articular | Orthopedic | |
| Ampio Pharmaceuticals Inc. | Ampion (AP-013) | Osteoarthritis of the Knee (OAK) | Phase 3 | Intra-articular | Orthopedic | |
| Amylyx Pharmaceuticals Inc. | AMX0035 - (ORION) | Progressive supranuclear palsy (PSP) | Phase 2b | Trial Discontinued | oral | Neurology |
| Amylyx Pharmaceuticals Inc. | Avexitide - (PREVENT) | Hyperinsulinemic hypoglycemia after bariatric or other gastrointestinal surgeries | Phase 2b | Data Released | Subcutaneous | Endocrinology |
| Amylyx Pharmaceuticals Inc. | RELYVRIO (sodium phenylbutyrate and taurursodiol) | Amyotrophic lateral sclerosis (ALS) | Phase 3 | Withdrawn | oral | Neurology |
